{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T02:05:08Z","timestamp":1785377108795,"version":"3.55.0"},"reference-count":10,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2019,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>A 78-year-old man with biochemically recurrent prostate adenocarcinoma (prostate-specific antigen, 2.3 ng\/mL) but without detectable disease in the chest, abdomen, or pelvis at conventional CT imaging or in the bones at <jats:sup>99m<\/jats:sup>Tc-MDP scintigraphy underwent <jats:sup>18<\/jats:sup>F-fluciclovine (anti\u20131-amino-3-<jats:sup>18<\/jats:sup>F-fluorocyclobutane-1-carboxylic acid) PET\/CT to evaluate for occult recurrent or metastatic disease. Imaging identified intense radiotracer uptake within 3 dural-based lesions along the left cerebral convexity. Subsequent MRI and biopsy confirmed multifocal World Health Organization grade 2 atypical meningiomas. Focal intracranial radiotracer uptake at <jats:sup>18<\/jats:sup>F-fluciclovine PET\/CT may create a diagnostic dilemma as incidental meningiomas can mimic intracranial metastases.<\/jats:p>","DOI":"10.1097\/rlu.0000000000002629","type":"journal-article","created":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T11:35:23Z","timestamp":1558352123000},"page":"594-595","source":"Crossref","is-referenced-by-count":7,"title":["Multifocal Meningiomas Mimicking Dural-Based Intracranial Metastases at 18F-Fluciclovine PET\/CT"],"prefix":"10.1097","volume":"44","author":[{"given":"Mark S.","family":"Manganaro","sequence":"first","affiliation":[{"name":"Lake Erie College of Osteopathic Medicine, Erie, PA;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John D.","family":"Millet","sequence":"additional","affiliation":[{"name":"Department of Radiology, Michigan Medicine; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew S.","family":"Manganaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2019,5,17]]},"reference":[{"key":"bib1-20230925","doi-asserted-by":"crossref","first-page":"413","DOI":"10.21037\/tau.2017.03.53","article-title":"Positron emission tomography (PET) in primary prostate cancer staging and risk assessment","volume":"6","year":"2017","journal-title":"Transl Androl Urol"},{"key":"bib2-20230925","doi-asserted-by":"crossref","first-page":"e386","DOI":"10.1097\/RLU.0000000000000849","article-title":"18F-fluciclovine PET\/CT for the detection of prostate cancer relapse: a comparison to 11C-choline PET\/CT","volume":"40","year":"2015","journal-title":"Clin Nucl Med"},{"key":"bib3-20230925","first-page":"305182","article-title":"Preliminary clinical experience of trans-1-Amino-3-(18)F-fluorocyclobutanecarboxylic Acid (anti-(18)F-FACBC) PET\/CT imaging in prostate cancer patients","volume":"2014","year":"2014","journal-title":"Biomed Res Int"},{"key":"bib4-20230925","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.wneu.2018.07.231","article-title":"Fluciclovine, anti-1-amino-3-[18F]-Fluorocyclobutane-1-carboxylic acid: a novel radiotracer for meningioma","volume":"119","year":"2018","journal-title":"World Neurosurg"},{"key":"bib5-20230925","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s00726-009-0394-9","article-title":"Positron emission tomography imaging of prostate cancer","volume":"39","year":"2010","journal-title":"Amino Acids"},{"key":"bib6-20230925","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1053\/hp.2000.6698","article-title":"Metastatic patterns of prostate cancer: an autopsy study of 1,589 patients","volume":"31","year":"2000","journal-title":"Hum Pathol"},{"key":"bib7-20230925","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.ejrad.2010.06.007","article-title":"Dural metastases from prostate carcinoma: a systematic review of the literature apropos of six patients","volume":"80","year":"2011","journal-title":"Eur J Radiol"},{"key":"bib8-20230925","first-page":"166","article-title":"Dural metastases in advanced prostate cancer: a case report and review of the literature","volume":"7","year":"2013","journal-title":"Curr Urol"},{"key":"bib9-20230925","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.jocn.2017.11.013","article-title":"Differentiating meningioma grade by imaging features on magnetic resonance imaging","volume":"48","year":"2018","journal-title":"J Clin Neurosci"},{"key":"bib10-20230925","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.2967\/jnumed.114.143628","article-title":"Anti-1-amino-3-18F-fluorocyclobutane-1-carboxylic acid: physiologic uptake patterns, incidental findings, and variants that may simulate disease","volume":"55","year":"2014","journal-title":"J Nucl Med"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00003072-201907000-00022","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T06:02:45Z","timestamp":1695621765000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003072-201907000-00022"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5,17]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000002629","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5,17]]}}}